Cargando…
The mechanism of activation of monomeric B-Raf V600E
Oncogenic mutations in the serine/threonine kinase B-Raf, particularly the V600E mutation, are frequent in cancer, making it a major drug target. Although much is known about B-Raf’s active and inactive states, questions remain about the mechanism by which the protein changes between these two state...
Autores principales: | Maloney, Ryan C., Zhang, Mingzhen, Jang, Hyunbum, Nussinov, Ruth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215184/ https://www.ncbi.nlm.nih.gov/pubmed/34188782 http://dx.doi.org/10.1016/j.csbj.2021.06.007 |
Ejemplares similares
-
Activation mechanisms of clinically distinct B‐Raf V600E and V600K mutants
por: Zhang, Mingzhen, et al.
Publicado: (2022) -
The mechanism of Raf activation through dimerization
por: Zhang, Mingzhen, et al.
Publicado: (2021) -
The mechanism of activation of MEK1 by B-Raf and KSR1
por: Maloney, Ryan C., et al.
Publicado: (2022) -
The quaternary assembly of KRas4B with Raf-1 at the membrane
por: Jang, Hyunbum, et al.
Publicado: (2020) -
Ras isoform-specific expression, chromatin accessibility, and signaling
por: Nussinov, Ruth, et al.
Publicado: (2021)